Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
2011
PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
2014
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
2014
Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade
2015
Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer
2011
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
2013
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
2011
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers
2014
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
2018
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
2013
Breast cancer
2016 Standout
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets
2013
Combining immunotherapy and targeted therapies in cancer treatment
2012
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
2017 StandoutNobel
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
2013
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
2014
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients
2010
HER2-Positive Circulating Tumor Cells in Breast Cancer
2011
Plasticity of disseminating cancer cells in patients with epithelial malignancies
2012
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
2013
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Immune parameters affecting the efficacy of chemotherapeutic regimens
2011
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Circulating tumour cells in non-metastatic breast cancer: a prospective study
2012
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Emerging Biological Principles of Metastasis
2017 Standout
EMT: 2016
2016 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
<em>nab</em>-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors
2016
Antiangiogenic therapy in oncology: current status and future directions
2016
Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
2016
Molecular mechanisms of metastasis in breast cancer—clinical applications
2010
Detection, clinical relevance and specific biological properties of disseminating tumour cells
2008
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
2016
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
2016
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Comprehensive Integration of Single-Cell Data
2019 Standout
Novel approaches to target the microenvironment of bone metastasis
2021
The Tumor-Immune Microenvironment and Response to Radiation Therapy
2010
Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology
2015
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Noncovalent Functionalization of Graphene and Graphene Oxide for Energy Materials, Biosensing, Catalytic, and Biomedical Applications
2016 Standout
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
Leukocyte composition of human breast cancer
2011
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Circulating Tumor Cells in Breast Cancer: Detection Systems, Molecular Characterization, and Future Challenges
2012
Breast Cancer Treatment
2019 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Immune targeting in breast cancer.
2015
Surgical treatment of primary breast cancer in the neoadjuvant setting
2014
Spermidine in health and disease
2018 StandoutScience
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Circulating Tumor Cells in Breast Cancer:Detection Systems, Molecular Characterization, and Future Challenges
2011
Prognostic and predictive value of PDL1 expression in breast cancer
2014
Metabolic reprogramming and cancer progression
2020 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Circulating Tumor Cells: Liquid Biopsy of Cancer
2012
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
2011
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Iris Schrader being referenced
Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial
2017
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer—results from the GeparQuattro study (GBG 40)
2011
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
2010
Neoadjuvant bevacizumab and anthracycline–taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
2013
Surgical Outcome after Neoadjuvant Chemotherapy and Bevacizumab: Results from the GeparQuinto Study (GBG 44)
2014
P1-14-05: Surgical Complications from the GeparQuinto Trial of Patients Receiving Preoperative Bevacizumab.
2011
Prospective monitoring of circulating tumor cells in breast cancer patients treated with primary systemic therapy—A translational project of the German Breast Group study GeparQuattro
2007
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
2009